Celltrion Obtains Final Sales Approval for COVID-19 Treatment Rekirona in Europe
[Asia Economy Reporter Minji Lee] Celltrion announced on the 15th that it has obtained the final EU sales approval for its COVID-19 treatment, Rekirona, from the European Commission (EC).
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
The company stated, "As COVID-19 cases continue to rise due to the prolonged pandemic, demand for COVID-19 treatments is expected to persist," adding, "It can contribute to normalizing the COVID-19 situation by reducing the rate at which existing patients' symptoms worsen to severe conditions or death."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
